Asia-Pacific Lipid POCT Market to 2032
Overview
The Asia-Pacific Lipid POCT Market is expected to reach a 287.91 USD Million by 2032 and is projected to grow at a CAGR of 10.70% from 2025 to 2032.
Revenue, 2024 (USD Million)
169.39
Forecast, 2032 (USD Million)
287.91
CAGR, 2024 - 2032
10.70%
Report Coverage
Asia-Pacific
Asia-Pacific Lipid POCT Market 2018-2032 USD Million
Asia-Pacific Lipid POCT Market, Key Findings (2025-2032)
Market Growth and Projections:
- Market Size (2024): 169.39 USD Million
- Projected Market Size (2032): 287.91 USD Million
- CAGR (2025-2032): 10.70%
Key Findings of Asia-Pacific Lipid POCT Market
- The Asia-Pacific Lipid POCT Market was valued at 169.39 USD Million in 2024.
- The Asia-Pacific Lipid POCT Market is likely to grow at a CAGR of 10.70% during the forecast period of 2024 to 2032.
- In 2024, the Largest segment Prescription-Based Testing in Mode Segment accounted for the largest share of the market with a revenue of 135.39 USD Million
- The fastest growing segment Hypertriglyceridemia in Application Segment grew Fastest with a CAGR of 13.77% during the forecast period from 2024 to 2032.
Asia-Pacific Lipid POCT Market Scope
Asia-Pacific Lipid POCT Market Segmentation & Scope
Application
- Others
- Tangier Disease
- Familial Hypercholesterolemia
- Hyperlipoproteinemia
- Hypertriglyceridemia
- Hyperlipidemia
Mode
- OTC-Based Testing
- Prescription-Based Testing
Brand
- PTS Cardiochek
- Alere Afinion
- Alere Cholestech LDX
- Others
- Roche Cobas B 101
- Roche Reflotron
Type
- Consumables And Kits
- Instruments
Platform
- Microfluidics
- Dipsticks
- Immunoassays
- Molecular Diagnostics
- Lateral Flow Assays /Immunochromatography Tests
End User
- Other End Users
- Research Laboratories
- Home Care
- Professional Diagnostic Centers
- Hospitals
Distribution Channel
- Retail Sales
- Direct Tenders
Asia-Pacific Lipid POCT Market Data Coverage Insights
| Study Period | 2024-2032 |
| Base Year | 2020 |
| Unit | Revenue in USD Million |
| Market Value in 2024 | 169.39 USD Million |
| Market Value in 2032 | 287.91 USD Million |
| CAGR (2025-2032) | 10.70% |
| Historic Data | 2016-2023 |
| Market Segments Covered | Application,Mode,Brand,Type,Platform,End User,Distribution Channel |
Regional Insights:
-
Leading Market (2024-2032): Asia-Pacific, leading in terms of revenue 169.39 USD Million in 2024
- Key Country: Japan, leading in terms of revenue with value of 47.53 USD Million in 2024.
Segments and Scope
-
Asia-Pacific Lipid POCT Market to 2032, By Application
- Hyperlipidemia is the largest segment in Asia-Pacific Lipid POCT Market to 2032 with a revenue of 101.12 USD Million in the year 2024.
- Hypertriglyceridemia is the Fastest growing segment in Asia-Pacific Lipid POCT Market to 2032 with a Growth rate of 9.93 % in forecast period 2025-2032.
-
Asia-Pacific Lipid POCT Market to 2032, By Mode
- Prescription-Based Testing is the largest segment in Asia-Pacific Lipid POCT Market to 2032 with a revenue of 135.39 USD Million in the year 2024.
- OTC-Based Testing is the Fastest growing segment in Asia-Pacific Lipid POCT Market to 2032 with a Growth rate of 10.23 % in forecast period 2025-2032.
-
Asia-Pacific Lipid POCT Market to 2032, By Brand
- Roche Reflotron is the largest segment in Asia-Pacific Lipid POCT Market to 2032 with a revenue of 86.73 USD Million in the year 2024.
- Alere Cholestech LDX is the Fastest growing segment in Asia-Pacific Lipid POCT Market to 2032 with a Growth rate of 10.85 % in forecast period 2025-2032.
-
Asia-Pacific Lipid POCT Market to 2032, By Type
- Instruments is the largest segment in Asia-Pacific Lipid POCT Market to 2032 with a revenue of 107.25 USD Million in the year 2024.
- Consumables And Kits is the Fastest growing segment in Asia-Pacific Lipid POCT Market to 2032 with a Growth rate of 9.97 % in forecast period 2025-2032.
-
Asia-Pacific Lipid POCT Market to 2032, By Platform
- Molecular Diagnostics is the largest segment in Asia-Pacific Lipid POCT Market to 2032 with a revenue of 54.26 USD Million in the year 2024.
- Molecular Diagnostics is the Fastest growing segment in Asia-Pacific Lipid POCT Market to 2032 with a Growth rate of 11.68 % in forecast period 2025-2032.
-
Asia-Pacific Lipid POCT Market to 2032, By End User
- Hospitals is the largest segment in Asia-Pacific Lipid POCT Market to 2032 with a revenue of 67.93 USD Million in the year 2024.
- Professional Diagnostic Centers is the Fastest growing segment in Asia-Pacific Lipid POCT Market to 2032 with a Growth rate of 10.47 % in forecast period 2025-2032.
-
Asia-Pacific Lipid POCT Market to 2032, By Distribution Channel
- Direct Tenders is the largest segment in Asia-Pacific Lipid POCT Market to 2032 with a revenue of 108.14 USD Million in the year 2024.
- Retail Sales is the Fastest growing segment in Asia-Pacific Lipid POCT Market to 2032 with a Growth rate of 10.46 % in forecast period 2025-2032.
Asia-Pacific Lipid POCT Market Company Share Analysis
| Company Name |
|
||
| Quest Diagnostics Incorporated | |||
| Abbott | |||
| A. Menarini Diagnostics s.r.l | |||
| F. Hoffmann-La Roche Ltd. | |||
| Siemens Healthcare GmbH | |||
Asia-Pacific Lipid POCT Market Geographical Sales Distribution, 2018-2032 USD Million
Asia-Pacific Lipid POCT Market Company Profiling
Industry Related Reports
Frequently Asked Questions
The Asia-Pacific Lipid POCT Market is segmented based on Segmentation Application,Mode,Brand,Type,Platform,End User,Distribution Channel.
Asia-Pacific Lipid POCT Market was valued at USD 169.39(Revenue in USD Million) in 2020.
Asia-Pacific Lipid POCT Market is projected to grow at a CAGR of 10.70% during the forecast period of 2024 to 2032.
The Prescription-Based Testing segment is expected to dominate the Asia-Pacific Lipid POCT Market, holding a largest market share of 135.39 USD Million in 2024
Asia-Pacific Lipid POCT Market Scope
Asia-Pacific Lipid POCT Market Segmentation & Scope
Application
- Others
- Tangier Disease
- Familial Hypercholesterolemia
- Hyperlipoproteinemia
- Hypertriglyceridemia
- Hyperlipidemia
Mode
- OTC-Based Testing
- Prescription-Based Testing
Brand
- PTS Cardiochek
- Alere Afinion
- Alere Cholestech LDX
- Others
- Roche Cobas B 101
- Roche Reflotron
Type
- Consumables And Kits
- Instruments
Platform
- Microfluidics
- Dipsticks
- Immunoassays
- Molecular Diagnostics
- Lateral Flow Assays /Immunochromatography Tests
End User
- Other End Users
- Research Laboratories
- Home Care
- Professional Diagnostic Centers
- Hospitals
Distribution Channel
- Retail Sales
- Direct Tenders
Frequently Asked Questions
The Asia-Pacific Lipid POCT Market is segmented based on Segmentation Application,Mode,Brand,Type,Platform,End User,Distribution Channel.
Asia-Pacific Lipid POCT Market was valued at USD 169.39(Revenue in USD Million) in 2020.
Asia-Pacific Lipid POCT Market is projected to grow at a CAGR of 10.70% during the forecast period of 2024 to 2032.
The estimated market value of the Asia-Pacific Lipid POCT Market for final year is USD 287.91 (USD Million).
Asia-Pacific Lipid POCT Market Company Profiling
Frequently Asked Questions
The Asia-Pacific Lipid POCT Market is segmented based on Segmentation Application,Mode,Brand,Type,Platform,End User,Distribution Channel.
Asia-Pacific Lipid POCT Market was valued at USD 169.39(Revenue in USD Million) in 2020.
Asia-Pacific Lipid POCT Market is projected to grow at a CAGR of 10.70% during the forecast period of 2024 to 2032.
The estimated market value of the Asia-Pacific Lipid POCT Market for final year is USD 287.91 (USD Million).
CHOOSE LICENCE TYPE
- 4200.00
- 3500.00
- 2000.00
- 5500.00
- 8500.00
HAVE A QUESTION?
Get expert advice on the right strategy for your business at no cost. We also offer customized subscription plans and affordable discounts for startups and universities.